271 related articles for article (PubMed ID: 15829534)
21. Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia.
Negrini M; Felix CA; Martin C; Lange BJ; Nakamura T; Canaani E; Croce CM
Cancer Res; 1993 Oct; 53(19):4489-92. PubMed ID: 8402620
[TBL] [Abstract][Full Text] [Related]
22. Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.
Infante Lara L; Fenner S; Ratcliffe S; Isidro-Llobet A; Hann M; Bax B; Osheroff N
Nucleic Acids Res; 2018 Mar; 46(5):2218-2233. PubMed ID: 29447373
[TBL] [Abstract][Full Text] [Related]
23. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
24. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
Epstein RJ; Smith PJ
Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of secondary acute promyelocytic leukemia.
Joannides M; Mays AN; Mistry AR; Hasan SK; Reiter A; Wiemels JL; Felix CA; Coco FL; Osheroff N; Solomon E; Grimwade D
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011045. PubMed ID: 22110895
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
[TBL] [Abstract][Full Text] [Related]
27. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
Lovett BD; Strumberg D; Blair IA; Pang S; Burden DA; Megonigal MD; Rappaport EF; Rebbeck TR; Osheroff N; Pommier YG; Felix CA
Biochemistry; 2001 Feb; 40(5):1159-70. PubMed ID: 11170441
[TBL] [Abstract][Full Text] [Related]
28. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the joining sequences of the t(15;17) translocation in human acute promyelocytic leukemia: sequence non-specific recombination between the PML and RARA genes within identical short stretches.
Yoshida H; Naoe T; Fukutani H; Kiyoi H; Kubo K; Ohno R
Genes Chromosomes Cancer; 1995 Jan; 12(1):37-44. PubMed ID: 7534109
[TBL] [Abstract][Full Text] [Related]
30. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
[TBL] [Abstract][Full Text] [Related]
31. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature.
Hoffmann L; Möller P; Pedersen-Bjergaard J; Waage A; Pedersen M; Hirsch FR
Ann Oncol; 1995 Oct; 6(8):781-8. PubMed ID: 8589015
[TBL] [Abstract][Full Text] [Related]
32. Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia.
Chillón MC; González M; García-Sanz R; Balanzategui A; González D; López-Pérez R; Mateos MV; Alaejos I; Rayón C; Arbeteta J; Hernández JM; Orfao A; San Miguel J
Genes Chromosomes Cancer; 2000 Jan; 27(1):35-43. PubMed ID: 10564584
[TBL] [Abstract][Full Text] [Related]
33. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
34. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
[TBL] [Abstract][Full Text] [Related]
35. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
36. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
[TBL] [Abstract][Full Text] [Related]
37. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
[TBL] [Abstract][Full Text] [Related]
38. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
Cowell IG; Sondka Z; Smith K; Lee KC; Manville CM; Sidorczuk-Lesthuruge M; Rance HA; Padget K; Jackson GH; Adachi N; Austin CA
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8989-94. PubMed ID: 22615413
[TBL] [Abstract][Full Text] [Related]
39. Therapy-related acute promyelocytic leukemia following etoposide-based chemotherapy in non-seminomatous germ cell tumor.
Kumar TN; ; Gandhi LV; Raghunadharao D; Sadashivudu G
J Postgrad Med; 2014; 60(1):84-5. PubMed ID: 24625948
[TBL] [Abstract][Full Text] [Related]
40. Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders.
Ottone T; Hasan SK; Voso MT; Ledda A; Montefusco E; Fenu S; Pagoni M; Hubmann M; Lunghi M; Platzbecker U; Lo-Coco F
Am J Hematol; 2014 Mar; 89(3):346-7. PubMed ID: 24375429
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
